4D Molecular Therapeutics, Inc. (FDMT) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript [Seeking Alpha]
4D Molecular Therapeutics, Inc. (FDMT)
Company Research
Source: Seeking Alpha
Company Participants Presentation Unknown Executive Good morning, everyone. I appreciate the time to share with you an overview of 4D Molecular Therapeutics. So we'll walk through today how 4DMT, we believe, is well positioned to redefine genetic medicines for millions of patients worldwide. I remind you here, we may be making forward-looking statements. So at 4DMT, our goal is to redefine genetic medicines by developing durable disease targeted therapeutics for large market diseases. Our lead product, which we'll spend most of the time discussing today is 4D-150. 4D-150 is a Phase III asset currently being studied in Phase III for wet AMD. And I'll share more around our development plans, notably our plans to initiate a trial later this year for diabetic macular edema. This slide recaps our development program. As I just mentioned, our focus right now is very clear. Our primary focus is on 4D-150 and as the slide suggests, we are in Phase III for wet AMD. And then later sl
Show less
Read more
Impact Snapshot
Event Time:
FDMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FDMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FDMT alerts
High impacting 4D Molecular Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FDMT
News
- 4DMT to Participate in Upcoming Investor MeetingsGlobeNewswire
- 4D Molecular Therapeutics Maps Phase 3 4D-150 Timeline, DME Expansion in Barclays Conference Talk [Yahoo! Finance]Yahoo! Finance
- 4D Molecular Therapeutics, Inc. (FDMT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street? [Yahoo! Finance]Yahoo! Finance
- 4DMT to Participate in Upcoming Investor ConferencesGlobeNewswire
FDMT
Earnings
- 11/10/25 - Beat
FDMT
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- FDMT's page on the SEC website